Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 577.0
(2.11%)
INR 577.0
(2.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 25.82 Billion INR | 15.74% |
| 2022 | 22.3 Billion INR | 1410835.31% |
| 2021 | 1.58 Million INR | -36.75% |
| 2020 | 2.5 Million INR | 0.0% |
| 2019 | 2.5 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 27.76 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 25.82 Billion INR | 15.74% |
| 2023 Q2 | 23.13 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 25.82 Billion INR | 0.0% |
| 2022 FY | 22.3 Billion INR | 1410835.31% |
| 2022 Q4 | 22.3 Billion INR | -0.71% |
| 2022 Q3 | 22.46 Billion INR | 0.0% |
| 2021 Q1 | 2.24 Million INR | 0.0% |
| 2021 FY | 1.58 Million INR | -36.75% |
| 2021 Q4 | 20.39 Billion INR | -0.0% |
| 2021 Q3 | 20.39 Billion INR | 909705.46% |
| 2021 Q2 | 2.24 Million INR | 0.0% |
| 2020 FY | 2.5 Million INR | 0.0% |
| 2019 FY | 2.5 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | 44.332% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -603.817% |
| Sigachi Industries Limited | 6.94 Billion INR | -271.977% |
| Bal Pharma Limited | 3.2 Billion INR | -705.927% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -121.619% |
| Medico Remedies Limited | 961.95 Million INR | -2584.227% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1611.488% |
| Venus Remedies Limited | 6.26 Billion INR | -311.93% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -401.34% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1313.906% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -17.847% |
| Shilpa Medicare Limited | 30.93 Billion INR | 16.523% |
| Aarti Drugs Limited | 24.32 Billion INR | -6.156% |
| Lupin Limited | 239.97 Billion INR | 89.24% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 94.271% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 91.182% |
| Windlas Biotech Limited | 6.26 Billion INR | -312.34% |
| Suven Life Sciences Limited | 2.84 Billion INR | -806.309% |
| Eris Lifesciences Limited | 70.48 Billion INR | 63.368% |
| Valiant Laboratories Limited | 3.42 Billion INR | -653.486% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 35.353% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -9.832% |
| Ipca Laboratories Limited | 111.01 Billion INR | 76.741% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -112.717% |
| Achyut Healthcare Limited | 309.52 Million INR | -8242.218% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 96.979% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -237.473% |
| RPG Life Sciences Limited | 5.12 Billion INR | -403.461% |
| Mankind Pharma Limited | 119.63 Billion INR | 78.416% |
| Laurus Labs Limited | 83.87 Billion INR | 69.213% |
| Piramal Pharma Limited | 153.11 Billion INR | 83.137% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -538.085% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 82.856% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 59.94% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 82.017% |
| Unichem Laboratories Limited | 31.69 Billion INR | 18.529% |
| Sequent Scientific Limited | 15.4 Billion INR | -67.627% |
| Novartis India Limited | 9.24 Billion INR | -179.167% |
| Wanbury Limited | 3.43 Billion INR | -651.718% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -14.552% |
| Wockhardt Limited | 76.49 Billion INR | 66.243% |
| Themis Medicare Limited | 5.66 Billion INR | -355.866% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1089.48% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 77.641% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 9.413% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 93.337% |
| Divi's Laboratories Limited | 154.7 Billion INR | 83.309% |
| NATCO Pharma Limited | 69.06 Billion INR | 62.612% |
| Gufic Biosciences Limited | 10.92 Billion INR | -136.339% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -15.046% |
| Ind-Swift Limited | 6.54 Billion INR | -294.532% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -225.054% |
| FDC Limited | 24.68 Billion INR | -4.619% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1349.196% |
| Granules India Limited | 55.2 Billion INR | 53.231% |
| Medicamen Biotech Limited | 2.94 Billion INR | -776.708% |
| Alkem Laboratories Limited | 155.74 Billion INR | 83.421% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -139.521% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -5384.18% |
| Brooks Laboratories Limited | 904.45 Million INR | -2754.872% |
| Megasoft Limited | 3.65 Billion INR | -605.685% |
| ZIM Laboratories Limited | 4.46 Billion INR | -477.881% |
| Strides Pharma Science Limited | 58.39 Billion INR | 55.784% |
| Neuland Laboratories Limited | 18.32 Billion INR | -40.901% |
| Morepen Laboratories Limited | 12.93 Billion INR | -99.667% |
| Hikal Limited | 24.87 Billion INR | -3.818% |
| Indoco Remedies Limited | 21.44 Billion INR | -20.393% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -975.599% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -674.419% |
| Hester Biosciences Limited | 6.62 Billion INR | -289.841% |